[We have episodes in German and English] How do scientists uncover phenomena and explain their connections? How do engineers design machines, methods and infrastructure? At omega tau, experts give detailed answers. Over the last ten years, we have produced 300 episodes in which we dug deeper, until we ran out of questions. Join us on our journey through the world of science and engineering: the closer you look and listen, the more interesting things get.
Rajiv Agarwal, MD, MS - HIF-PH Inhibitors: An Emerging Strategy for Managing Anemia in Patients With Chronic Kidney Disease
Manage episode 295956741 series 103582
Player FM과 저희 커뮤니티의 PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
Go online to PeerView.com/TWS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live web broadcast, experts on anemia management in chronic kidney disease (CKD) highlight the latest evidence for HIF-PH inhibitors and provide expert guidance on integrating these advances into clinical practice. Upon completion of this accredited CE activity, participants should be better able to: Review the prevalence, burden, and pathophysiology associated with anemia among patients with CKD, Identify the benefits and limitations of current therapeutic strategies to manage anemia associated with CKD, Assess the safety and efficacy data of HIF-PH inhibitors in patients with anemia in dialysis-dependent (DD)-CKD or nondialysis-dependent (NDD)-CKD, Personalize treatment of anemia in patients with CKD in accordance with current evidence, expert recommendations, and individual patient needs.